Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

No studies found 5 · 71.4%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 28.6%Moderate 0 · 0%High 0 · 0%

ASAS 40 · Patients with AS

The review found no eligible studies for this question.

1 finding from 1 review

Methotrexate for ankylosing spondylitis 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Partial remission ( · Patients with AS

The review found no eligible studies for this question.

1 finding from 1 review

Methotrexate for ankylosing spondylitis 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

BASFI (score from 0 to 10, 0=excellent, 10=poor function) · Patients with AS

1 finding from 1 review

Methotrexate for ankylosing spondylitis 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 35 participants
Low

X‐Ray of the spine · Patients with AS

The review found no eligible studies for this question.

1 finding from 1 review

Methotrexate for ankylosing spondylitis 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

MRI · Patients with AS

The review found no eligible studies for this question.

1 finding from 1 review

Methotrexate for ankylosing spondylitis 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Serious adverse event · Patients with AS

The review found no eligible studies for this question.

1 finding from 1 review

Methotrexate for ankylosing spondylitis 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Withdrawals due to any reason · Patients with AS

MTX treated showed no clear difference in withdrawal for any reason compared with no MTX treated (low certainty).

1 finding from 1 review

Methotrexate for ankylosing spondylitis 2013 · Cochrane Headline outcomes only
RR 1.06 [0.07, 15.62]
1 study · 35 participants
Low